You are here

Article info

Article menu
Congenital heart disease
Original research
Sacubitril/valsartan in the treatment of systemic right ventricular failure

Authors

  1. Correspondence to Dr. Anastasia D Egorova, Cardiology, Leids Universitair Medisch Centrum HartLong Centrum Leiden, Leiden 2333 ZA, Zuid Holland, The Netherlands; a.egorova{at}lumc.nl
View Full Text

Citation

Zandstra TE, Nederend M, Jongbloed MRM, et al
Sacubitril/valsartan in the treatment of systemic right ventricular failure
Heart 2021;107:1725-1730.

Publication history

  • Received September 3, 2020
  • Revised November 19, 2020
  • Accepted December 17, 2020
  • First published January 15, 2021.
Online issue publication 
May 06, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.